Wednesday February 10 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

TARCEVA Pages on BioPortfolio:

Biotechnology News TARCEVA Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/TARCEVA-news.htm...

Combining Avastin and Tarceva as a synergistic approach to cancer?
The development of Avastin (bevacizumab) and Tarceva are promising to improve this situation as well as offering hope to other patients with diverse cancers
...
http://www.bioportfolio.com/LeadDiscovery/PubMed-030511.html...

Biotechnology News Osi Search
The FDA has extended the review period for OSI Pharmaceuticals and Genentechs sNDA for Tarceva (erlotinib) as a first-line maintenance therapy in advanced ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Tarceva
Panel Votes Against Approval of Tarceva(R) as Maintenance Drug WASHINGTON, Dec. 17 /PRNewswire-USNewswire/ -- Yesterday, an advisory committee to the Food ...
http://www.bioportfolio.com/indepth/Tarceva.html...

Biotechnology News TAXOTERE Search
WASHINGTON -- Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a ...
http://www.bioportfolio.co.uk/TAXOTERE-news.htm...

BioPortfolio - OSI Pharmaceuticals - Profile
UPDATE 1-OSI Pharma says FDA extends Tarceva review ... OSI Pharma, Genentech Say FDA Extends Review Period Of Tarceva SNDA For Use In Lung Cancer - ...
http://www.bioportfolio.com/biocorporate/7940-OSI%2525252525...

Biotechnology News patent Search
OSI Pharmaceuticals, Inc announced that the US Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's (erlotinib) ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=ne...

The Board of International Biotechnology Trust Plc (“IBT”) today ...
In mid-November 2004, OSI Pharmaceuticals and partner Genentech announced the approval of OSIs lead drug Tarceva to treat non-small cell carcinoma (NSCLC).
...
http://www.bioportfolio.com/news/International_Biotechnology...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

Cyclacel (NASDAQ:CYCC) appoints Nicholas Bacopoulos, Ph.D. to ...
He was previously President and Head of R&D at OSI Pharmaceuticals, where he was involved with the global development of Tarceva®, approved for the ...
http://www.bioportfolio.com/biotech_news/Cyclacel_Pharmaceut...

Results from other life science and pharmaceutical sites:

Genentech: Medicines: Tarceva
Tarceva is a selective and orally active inhibitor of the Epidermal Growth Factor Receptor (EGFR), tyrosine kinase, that is associated with the aberrant
...
http://www.gene.com/gene/products/information/oncology/tarce...

Erlotinib - Wikipedia, the free encyclopedia
Erlotinib hydrochloride (Tarceva) is a drug used to treat non-small cell lung .... Tarceva has been shown to extend the lives of some cancer patients and to
...
http://en.wikipedia.org/wiki/Erlotinib...

Genentech: Medicines: Tarceva Fact Sheet
Skip to Content for Tarceva Fact Sheet Menu for Tarceva Fact Sheet About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu ...
http://www.gene.com/gene/products/information/oncology/tarce...

FINAL 30April 2009 PI-Clean
TARCEVA safely and effectively. See full prescribing information for .... showed no clinical benefit with the concurrent administration of TARCEVA with ...
http://www.osip.com/full_PI_tarceva...

Genentech: Investors: Tarceva - Historical Sales
Skip to Content for Tarceva - Historical Sales Menu for Tarceva - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/tarceva.ht...

Roche - Tarceva (Erlotinib)
Skip over Breadcrumb. You are here: Products: > Tarceva (Erlotinib). Tarceva ( Erlotinib). For the treatment of patients with lung and pancreatic cancer. ...
http://www.roche.com/products/product-details.htm?type=produ...

Tarceva template
18 Nov 2004 ... To review data supporting the need for new treatment options for patients with pancreatic cancer; To present evidence that Tarceva, ...
http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4174S1_05...

Roche - New cancer drug Tarceva - a breakthrough with significant ...
26 Apr 2004 ... Roche, Genentech, Inc. and OSI Pharmaceuticals, Inc., today announced positive results from a phase III study of Tarceva (erlotinib) in ...
http://www.roche.com/med-cor-2004-04-26b...

Tarceva (erlotinib) May 2009
8 May 2009 ... Dear Healthcare Professional letter issued to warn about GI perforation, exfoliative skin conditions and corneal perforation/ulceration.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...

Overcoming acquired resistance to Iressa/Tarceva with inhibitors ...
However, the remissions induced by these drugs (Iressa and Tarceva) are typically short-lived, presumably due to acquired drug resistance. ...
http://www.ncbi.nlm.nih.gov/pubmed/15970680...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.